APOE and Alzheimer disease: According to recent studies (Ridge et al., 2013), about 33% of the variation of the AD phenotype can be explained by common variation sites, among which APOE accounts for 6%, while other known variation sites account for 2%, which means that about 25% of the variation of the AD phenotype is still not explained by common variation sites.